- Home
- ATNM vs AIRG Comparison
ATNM vs AIRG Comparison
Compare ATNM & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- AIRG
- Stock Information
- Founded
- ATNM 2000
- AIRG 1995
- Country
- ATNM United States
- AIRG United States
- Employees
- ATNM N/A
- AIRG N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- AIRG Radio And Television Broadcasting And Communications Equipment
- Sector
- ATNM Health Care
- AIRG Technology
- Exchange
- ATNM Nasdaq
- AIRG Nasdaq
- Market Cap
- ATNM 50.2M
- AIRG 48.9M
- IPO Year
- ATNM N/A
- AIRG 2016
- Fundamental
- Price
- ATNM $1.63
- AIRG $4.31
- Analyst Decision
- ATNM Strong Buy
- AIRG Strong Buy
- Analyst Count
- ATNM 2
- AIRG 3
- Target Price
- ATNM $4.50
- AIRG $8.50
- AVG Volume (30 Days)
- ATNM 130.6K
- AIRG 29.6K
- Earning Date
- ATNM 11-13-2025
- AIRG 11-11-2025
- Dividend Yield
- ATNM N/A
- AIRG N/A
- EPS Growth
- ATNM N/A
- AIRG N/A
- EPS
- ATNM N/A
- AIRG N/A
- Revenue
- ATNM N/A
- AIRG $56,820,000.00
- Revenue This Year
- ATNM N/A
- AIRG N/A
- Revenue Next Year
- ATNM N/A
- AIRG $21.58
- P/E Ratio
- ATNM N/A
- AIRG N/A
- Revenue Growth
- ATNM N/A
- AIRG 6.84
- 52 Week Low
- ATNM $1.03
- AIRG $3.17
- 52 Week High
- ATNM $2.41
- AIRG $10.34
- Technical
- Relative Strength Index (RSI)
- ATNM 46.73
- AIRG 49.86
- Support Level
- ATNM $1.52
- AIRG $4.10
- Resistance Level
- ATNM $1.70
- AIRG $4.40
- Average True Range (ATR)
- ATNM 0.07
- AIRG 0.20
- MACD
- ATNM -0.01
- AIRG -0.00
- Stochastic Oscillator
- ATNM 36.71
- AIRG 59.57
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.